Sujay Kango, EVP, Chief Commercial Officer at ACCELERON PHARMA INC (XLRN), sold 9,200 shares at $135.48 ($1.3M) on 2021-03-02, disclosed to the SEC on 2021-03-04.
Open-market sale of $1.3M XLRN by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.48 | 2,699 | $366K | 29.2% |
| 2 | $135.48 | 2,699 | $366K | 29.2% |
| 3 | $136.24 | 1,501 | $204K | 16.4% |
| 4 | $136.24 | 1,501 | $204K | 16.4% |
| 5 | $137.12 | 600 | $82K | 6.6% |
| 6 | $138.15 | 200 |
| $28K |
| 2.2% |
| Total | $135.89 avg | 9,200 | $1.3M | 100% |
| Filing → |
| XLRN | SELL | 2021-01-06 | $2.5M | — | Filing → |
| XLRN | SELL | 2020-02-14 | $112K | — | Filing → |
| XLRN | SELL | 2020-01-03 | $25K | — | Filing → |